Top biotech deals in October 2026
The most expensive biotech M&A in October 2026 was worth $2 billion. Licensing deals spanned across therapeutic technologies. The post Top biotech deals in October 2026 appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts…
We haven't written up this one. Labiotech has the full story — the link below goes straight to it.
